These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35676602)

  • 1. Formulation and Pharmacokinetic Evaluation of Ethyl Cellulose/HPMC-Based Oral Expandable Sustained Release Dosage of Losartan Potassium.
    Wani TU; Fazli AA; Raza SN; Khan NA; Sheikh FA
    AAPS PharmSciTech; 2022 Jun; 23(5):160. PubMed ID: 35676602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan potassium sustained release pellets with improved
    Abou Obaid NI; Al-Jenoobi FI; Ibrahim MA; Alam MA
    Pharm Dev Technol; 2020 Nov; 25(9):1031-1042. PubMed ID: 32538215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers.
    Zaidenstein R; Soback S; Gips M; Avni B; Dishi V; Weissgarten Y; Golik A; Scapa E
    Ther Drug Monit; 2001 Aug; 23(4):369-73. PubMed ID: 11477318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan Potassium and Verapamil Hydrochloride Compound Transdermal Drug Delivery System: Formulation and Characterization.
    Chen YS; Sun YY; Qin ZC; Zhang SY; Chen WB; Liu YQ
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study.
    Sankar R; Jain SK
    Drug Des Devel Ther; 2013; 7():1455-69. PubMed ID: 24348022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porous carrier based floating granular delivery system of repaglinide.
    Jain SK; Agrawal GP; Jain NK
    Drug Dev Ind Pharm; 2007 Apr; 33(4):381-91. PubMed ID: 17523003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
    Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
    Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence study of two losartan formulations administered orally in healthy male volunteers.
    Bienert A; Brzezińiski R; Szałek E; Dubai V; Grześkowiak E; Dyderski S; Drobnik L; Wolc A; Olejniczak-Rabinek M
    Arzneimittelforschung; 2006; 56(11):723-8. PubMed ID: 17220048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits.
    Bouriche S; Alonso-García A; Cárceles-Rodríguez CM; Rezgui F; Fernández-Varón E
    BMC Vet Res; 2021 Sep; 17(1):315. PubMed ID: 34563196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of swelling/floating gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphism.
    Chen RN; Ho HO; Yu CY; Sheu MT
    Eur J Pharm Sci; 2010 Jan; 39(1-3):82-9. PubMed ID: 19903527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative bioavailability of two losartan formulations in healthy human volunteers after a single dose administration.
    Oliveira CH; Medeiros Silva R; Santagada V; Caliendo G; Perissutti E; Prado Galuppo M; Marcondes Rezende V; Barrientos-Astigarraga RE; Mendes GD; De Nucci G
    Int J Clin Pharmacol Ther; 2006 Mar; 44(3):142-8. PubMed ID: 16550737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
    Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
    J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs.
    Shin S; Kim TH; Jeong SW; Chung SE; Lee DY; Kim DH; Shin BS
    PLoS One; 2019; 14(5):e0216875. PubMed ID: 31091273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of dexibuprofen formulation with fast onset and prolonged effect.
    Choi Y; Min KA; Kim CK
    Drug Dev Ind Pharm; 2019 Jun; 45(6):895-904. PubMed ID: 30889990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of sustained release floating drug delivery system for norfloxacin: in vitro and in vivo evaluation.
    Guguloth M; Bomma R; Veerabrahma K
    PDA J Pharm Sci Technol; 2011; 65(3):198-206. PubMed ID: 22293231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.